1. Introduction
===============

Transition-metal-catalyzed cyclization of alkynes with nitrogen-containing compounds has provided the efficient synthetic methods for *N*-heterocyclic compounds \[[@B1-ijms-16-03599],[@B2-ijms-16-03599],[@B3-ijms-16-03599],[@B4-ijms-16-03599]\]. With the interest of developing the efficient procedures approach to *N*-heterocyclic compounds, we have recently studied the cyclization of alkynes or 1,3-butadiynes with various nitrogen-containing compounds affording 1,2,5-trisubsituted pyrroles \[[@B5-ijms-16-03599]\], isoquinolines \[[@B6-ijms-16-03599],[@B7-ijms-16-03599]\], 2,4,6-triarylpyridines \[[@B8-ijms-16-03599]\], benzo\[*f*\]quinazolines \[[@B9-ijms-16-03599]\], indoles \[[@B10-ijms-16-03599]\], ring-fused phenanthroimidazoles \[[@B11-ijms-16-03599]\], and 1,2,4-oxadiazoles \[[@B12-ijms-16-03599]\]. On the other hand, cyclic compounds containing the structural unit of 2,5-dimethylpyrazine (DMP) show interesting physiological and biological activities found to be the pheromone of ants \[[@B13-ijms-16-03599],[@B14-ijms-16-03599]\], and fungicide active agents \[[@B15-ijms-16-03599]\] ([Scheme 1](#ijms-16-03599-f001){ref-type="scheme"}). In addition, the structural unit of DMP has become increasingly important applications as versatile ligands in the field of supramolecular chemistry due to their coordinative ability of two symmetric nitrogen atoms \[[@B16-ijms-16-03599],[@B17-ijms-16-03599],[@B18-ijms-16-03599],[@B19-ijms-16-03599],[@B20-ijms-16-03599]\].

![Examples of natural products having structural unit of 2,5-dimethylpyrazine (DMP).](ijms-16-03599-g001){#ijms-16-03599-f001}

It has been well documented that propargylic compounds, such as propargyl amines \[[@B21-ijms-16-03599],[@B22-ijms-16-03599]\], and propargyl alcohols \[[@B23-ijms-16-03599],[@B24-ijms-16-03599],[@B25-ijms-16-03599]\] have been widely applied as one of the important building blocks in the synthesis of a variety of heterocyclic compounds containing the relevant heteroatoms. As a continuation of our interest in the applications of propargylic compounds on the synthesis of heterocyclic compounds \[[@B23-ijms-16-03599],[@B24-ijms-16-03599],[@B25-ijms-16-03599]\], we are interested in exploring the possible application of prop-2-yn-1-amine (a simplest molecule of propargyl amine) in the synthesis of DMP. Therefore, we designed a synthetic protocol for the formation of DMP as shown in [Scheme 2](#ijms-16-03599-f002){ref-type="scheme"}. It involves the dimerization of propargyl amines via the hydroamination to give α-amino enamine **A** and its rearranged isomer **A\'**, which serves as a nucleophile to undergo the aldol addition with aldehyde to form α-amino imine intermediate **B** \[[@B26-ijms-16-03599]\]. The subsequent intramolecular hydroamination and dehydration/isomerization form cyclic structure of pyrazine. After we developed the catalytic system and finished the experiments \[[@B27-ijms-16-03599]\], a similar procedure for the formation of pyrazine ring was recently reported \[[@B28-ijms-16-03599]\].

![Proposed mechanism for the formation of pyrazine's ring.](ijms-16-03599-g002){#ijms-16-03599-f002}

2. Results and Discussion
=========================

We initiated our investigation on the reaction of prop-2-yn-1-amine with benzaldehyde (**1a**) in presence of Au(I) complexes, since Au(I) complexes have been found to be the efficient catalysts for the intermolecular \[[@B29-ijms-16-03599],[@B30-ijms-16-03599]\] and intramolecular hydroamination of alkynes \[[@B31-ijms-16-03599],[@B32-ijms-16-03599],[@B33-ijms-16-03599]\], as well as cycloisomerization of alkynes \[[@B34-ijms-16-03599],[@B35-ijms-16-03599]\] to give *N*-heterocyclic compounds. As concluded in [Table 1](#ijms-16-03599-t001){ref-type="table"}, when a mixture of benzaldehyde (1.0 mmol, **1a**) and propargyl amine (3.0 equiv) and Au(PPh~3~)Cl (0.05 mmol) in toluene was heated with stirring at 60 °C for 48 h, the analyses of the reaction mixture by GC-MS revealed that a new dehydrative cyclization of one molecule of **1a** with two molecules of propargyl amine occurred to produce 3-benzyl-2,5-dimethylpyrazine (**2a**) in 13% GC yield (entry 1). The formation of **2a** greatly depended on the solvents used. For example, when THF was used to lead to no formation of **2a** at all (entry 2). However, the yield of **2a** could be substantially increased to 45%, when CH~3~CN was employed (entry 3). Increasing the reaction temperature to 80 °C in CH~3~CN resulted in the reaction much more efficiently to afford **2a** in 77% yield (entry 4), and the almost quantitative yields of **2a** could be obtained by simply replacing PPh~3~ ligand to PPh~2~Me (entry 5) or PPh~2~Cy (entry 6) in CH~3~CN at 60 °C. In the presence of Au(PPh~2~Cy)Cl, repeating the reaction in toluene (entry 7) and THF (entry 8) resulted in low yield or no formation of **2a**. In addition, Au(PPhMe~2~)Cl and Au(PCy~3~)Cl also showed good catalytic activities to give **2a** in 72% (entry 9) and 88% GC (entry 10) yields, respectively. It should be noted that reduction of reaction time to 24 h led to the slight decrease of the yields of **2a** in the cases of Au(PPh~2~Me)Cl (entry 11, 89%) and Au(PPh~2~Cy)Cl (entry 12, 92%) used.

ijms-16-03599-t001_Table 1

###### 

Optimizing the reaction conditions for the formation of 3-benzyl-2,5-dimethylpyrazine (**2a**) *^a^*.

  ![](ijms-16-03599-i001.jpg)                                      
  ----------------------------- ---------------- --------- ------- -----------
  1                             Au(PPh~3~)Cl     toluene   60/48   13
  2                             Au(PPh~3~)Cl     THF       60/48   0
  3                             Au(PPh~3~)Cl     CH~3~CN   60/48   45
  4                             Au(PPh~3~)Cl     CH~3~CN   80/48   77
  5                             Au(PPh~2~Me)Cl   CH~3~CN   60/48   \>99
  6                             Au(PPh~2~Cy)Cl   CH~3~CN   60/48   \>99 (92)
  7                             Au(PPh~2~Cy)Cl   toluene   60/48   20
  8                             Au(PPh~2~Cy)Cl   THF       60/48   0
  9                             Au(PPhMe~2~)Cl   CH~3~CN   60/48   72
  10                            Au(PCy~3~)Cl     CH~3~CN   60/48   88
  11                            Au(PPh~2~Me)Cl   CH~3~CN   60/24   89
  12                            Au(PPh~2~Cy)Cl   CH~3~CN   60/24   92

*^a^* Reactions were carried out using 1.0 mmol of benzaldehyde (**1a**), 3.0 mmol of pro-2-yn-1-amine, and 0.05 mmol of catalyst in 2.0 mL of solvent in a sealed tube under nitrogen atmosphere; *^b^* GC yield based on the amount of **1a** used. Number in parenthesis is isolated yield.

With the optimized reaction condition indicated in entry 6 of [Table 1](#ijms-16-03599-t001){ref-type="table"}, the generality for the formation of 3-substituted 2,5-dimethylpyrazines was studied. As shown in [Table 2](#ijms-16-03599-t002){ref-type="table"}, benzaldehydes bearing chloro group at *para*-, *meta*- or *ortho*-position, or having bromo, fluoro, methyl or methoxy group at *para*-position reacted with propargyl amine smoothly to afford the corresponding pyrazines **2b**--**f** and **2h**--**i** in high yields. No significant steric effect was observed when *para*-chlorobenzaldehyde (for **2b**), *meta*-chlorobenzaldehyde (for **2c**) and *ortho*-chlorobenzaldehyde (for **2d**) were used, and the desired products **2b**--**d** were obtained in similar yields. By comparison of the reactions in the cases of *para*-chlorobenzaldehyde (for **2b**), *para*-fluorobenzaldehyde (for **2e**), *para*-methylbenzaldehyde (for **2h**) and *para*-methoxybenzaldehyde (for **2i**) used, the electron effect of substitute groups could not affect the formation of the corresponding pyrazines in high yields either. Only in the case of 2,4-dichlorobenzaldehyde employed, the corresponding product was formed in a declined yield (**2g**, 73%). In addition, it was very important to note that under the reaction conditions, C--X bond (X = F, Cl, Br) remained intact, and the obtained 3-arylmethyl-2,5-dimethylpyrazines can be easily transferred into their new derivatives by C--X bond activation and its coupling reaction. In addition, we also examined the present cyclization employing aliphatic aldehydes, and the reactions occurred smoothly to afford the corresponding desired pyrazines (**2k**--**m**) with high yields.

ijms-16-03599-t002_Table 2

###### 

Synthesis of 2,5-dimethylpyrazine derivatives ^a^.

  -----------------------------
  ![](ijms-16-03599-i002.jpg)
  -----------------------------

^a^ Reactions were carried out using 2.0 mmol of aldehyde, 6.0 mmol of prop-2-yn-1-amine, and 0.1 mmol of catalyst in 4.0 mL of MeCN at 60 °C for 48 h.

Moreover, the annulation of propargyl amine with heterocyclic aldehydes such as 2-furaldehyde and 2-thiophenaldehyde were also studied, and in the case of 2-furaldehyde used, the corresponding 2,5-dimethylpyrazine (**2n**) was obtained in high yield. However, when 2-thiophenaldehyde was subjected to the similar reaction conditions, the desired product (**2o**) formed in 19% isolated yield, accompanied with the formation of *N*-(prop-2-yn-1-yl)-1-thiophen-2-ylmethanimine in 70% yield resulting from the traditional nucleophilic addition of propargyl amine to aldehyde and subsequent dehydration reaction.

However, unfortunately, the reactions of **1a** or **1k** with 3-substituted propargyl amines such as 3-phenyl-2-propyn-1-amine and 2-heptyn-1-amine resulted in neither affording the corresponding pyrazine derivatives, nor forming other *N*-heterocyclic compounds.

3. Experimental Section
=======================

3.1. General Methods
--------------------

All organic starting materials and solvents are analytically pure and used without further purification. Nuclear magnetic resonance (NMR) spectra were recorded on a JEOL ECA-300 spectrometer (JEOL, Tokyo, Japan) using CDCl~3~ as a solvent at 298 K. ^1^H NMR (300 MHz) chemical shifts (δ) were referenced to internal standard TMS (for ^1^H, δ = 0.00 ppm). ^13^C NMR (75 MHz) chemical shifts were referenced to internal solvent CDCl~3~ (for ^13^C, δ = 77.16 ppm). Mass spectra (MS) were obtained on a Shimadzu GCMS-QP2010S (Shimadzu, Tokyo, Japan), and high-resolution mass spectra (ESI) were obtained with a micrOTOF-Q 10142 spectrometer (Agilent, San Diego, CA, USA).

3.2. A Typical Experiment Procedure for the Reaction of Benzaldehyde (**1a**) with Prop-2-yn-1-amine Affording 3-Benzyl-2,5-dimethylpyrazine (**2a**) ([Table 1](#ijms-16-03599-t001){ref-type="table"}, Entry 6)
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

A mixture of benzaldehyde (**1a**) (106.0 mg, 1.0 mmol), prop-2-yn-1-amine (165.0 mg, 3.0 mmol), Au(PPh~2~Cy)Cl (25.0 mg, 0.05 mmol) and CH~3~CN (2.0 mL) was heated at 60 °C (oil bath temperature) with stirring for 48 h in a screw-capped thick-walled Pyrex tube under a nitrogen atmosphere. After the reaction mixture was cooled to room temperature, CH~2~Cl~2~ (3.0 mL) and *n*-octadecane (51.0 mg, 0.2 mmol as internal standard for GC analysis) was then added with stirring. After GC and GC-MS analyses of the reaction mixture, volatiles were removed under reduced pressure, and the residue was subjected to silica gel column chromatography (silica gel was alkalized by a solution of petroleum ether with 2% (*v*/*v*) triethylamine), eluted with a mixture of solvents of triethylamine/ethyl acetate/petroleum ether (1:20:80 in volume). **2a** was obtained in 182.0 mg (0.92 mmol, 92%) as a yellow oil. The GC analysis of reaction mixture disclosed the formation of **2a** in \>99% GC yield.

Characterization data of products (the charts of ^1^H- and ^13^C-NMR are reported in [Supplementary Materials](#app1-ijms-16-03599){ref-type="app"}):

**3-Benzyl-2,5-dimethylpyrazine (2a) \[[@B36-ijms-16-03599]\]:** yellow oil; ^1^H NMR (300 MHz, CDCl~3~) δ 8.20 (s, 1H), 7.28--7.15 (m, 5H), 4.15 (s, 2H), 2.51 (s, 3H), 2.43 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 152.9, 150.1, 149.3, 141.4, 137.9, 128.6, 128.4, 126.4, 41.6, 21.4, 21.0; GCMS *m*/*z* (% rel. intensity) 198 (M^+^, 66), 197 (100), 183 (40), 128 (8), 91 (14); HRMS (ESI): Calcd. for C~13~H~15~N~2~ \[M + H\]^+^: 199.1230; found: 199.1232.

**3-(4-Chlorobenzyl)-2,5-dimethylpyrazine (2b):** yellow oil; ^1^H NMR (300 MHz, CDCl~3~) δ 8.22 (s, 1H), 7.22 (d, 2H, *J* = 8.6 Hz), 7.11 (d, 2H, *J* = 8.3 Hz), 4.11 (s, 2H), 2.51 (s, 3H), 2.43 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 153.3, 150.3, 149.1, 141.5, 136.4, 132.2, 129.9, 128.5, 40.8, 21.3, 21.0; GCMS *m*/*z* (% rel. intensity) 233 (44), 232 (M^+^, 79), 231 (100), 217 (34), 197 (23), 196 (24), 182 (17); HRMS (ESI): Calcd. for C~13~H~14~ClN~2~ \[M + H\]^+^: 233.0840; found: 233.0844.

**3-(3-Chlorobenzyl)-2,5-dimethylpyrazine (2c):** yellow oil; ^1^H NMR (300 MHz, CDCl~3~) δ 8.23 (s, 1H), 7.25--7.12 (m, 3H), 7.07 (m, 1H), 4.13 (s, 2H), 2.52 (s, 3H), 2.45 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 152.1, 150.4, 149.2, 141.7, 140.0, 134.3, 129.7, 128.6, 126.8, 126.6, 41.1, 21.4, 21.1; GCMS *m*/*z* (% rel. intensity) 233 (41), 232 (M^+^, 76), 231 (100), 217 (47), 197 (24), 196 (27), 182 (19), 116 (22); HRMS (ESI): Calcd. for C~13~H~14~ClN~2~ \[M + H\]^+^: 233.0840; found: 233.0847.

**3-(2-Chlorobenzyl)-2,5-dimethylpyrazine (2d):** yellow oil; ^1^H NMR (300 MHz, CDCl~3~) δ 8.24 (s, 1H), 7.38 (d, 1H, *J* = 7.9 Hz), 7.20--7.08 (m, 2H), 6.88 (d, 1H, *J* = 7.2 Hz), 4.27 (s, 2H), 2.50 (s, 3H), 2.43 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 152.0, 150.4, 149.6, 141.6, 136.0, 134.1, 129.9, 129.4, 127.8, 126.8, 38.6, 21.3, 21.1; GCMS *m*/*z* (% rel. intensity) 197 (100), 116 (8), 89 (7); HRMS (ESI): Calcd. for C~13~H~14~ClN~2~ \[M + H\]^+^: 233.0840; found: 233.0838.

**3-(4-Fluorobenzyl)-2,5-dimethylpyrazine (2e):** yellow oil; ^1^H NMR (300 MHz, CDCl~3~) δ 8.22 (s, 1H), 7.20--2.09 (m, 2H), 6.97--6.90 (m, 2H), 4.12 (s, 2H), 2.52 (s, 3H), 2.44 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 161.5 (d, *J*~C--F~ = 242.4 Hz), 152.7, 150.3, 149.1, 141.5, 133.6 (d, *J*~C--F~ = 2.9 Hz), 130.0 (d, *J*~C--F~ = 7.9 Hz), 115.2 (d, *J*~C--F~ = 20.8 Hz), 40.7, 21.3, 21.0; GCMS *m/z* (% rel. intensity) 216 (M^+^, 71), 215 (100), 201 (38), 109 (22); HRMS (ESI): Calcd. for C~13~H~14~FN~2~ \[M + H\]^+^: 217.1136; found: 217.1126.

**3-(2-Bromobenzyl)-2,5-dimethylpyrazine (2f):** yellow solid; ^1^H NMR (300 MHz, CDCl~3~) δ 8.24 (s, 1H), 7.56 (d, 1H, *J* = 6.5 Hz), 7.20--7.01 (m, 2H), 6.84 (d, 1H, *J* = 7.6 Hz), 4.26 (s, 2H), 2.49 (s, 3H), 2.43 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 151.9, 150.3, 149.6, 141.6, 137.7, 132.7, 129.9, 128.0, 127.4, 124.7, 41.3, 21.3, 31.1; GCMS *m*/*z* (% rel. intensity) 197 (M--Br^−^, 100), 154 (5), 128 (10), 89 (9), 63 (5); HRMS (ESI): Calcd. for C~13~H~14~BrN~2~ \[M + H\]^+^: 277.0335; found: 277.0327.

**3-(2,4-Dichlorobenzyl)-2,5-dimethylpyrazine (2g):** yellow oil; ^1^H NMR (300 MHz, CDCl~3~) δ 8.24 (s, 1H), 7.40 (s, 1H), 7.12 (d, 1H, *J* = 7.5 Hz), 6.86 (d, 1H, *J* = 8.2 Hz), 4.21 (s, 2H), 2.49 (s, 3H), 2.44 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 151.5, 150.6, 149.5, 141.8, 134.7, 133.5, 132.9, 131.0, 129.2, 127.1, 38.0, 21.3, 21.1; GCMS *m*/*z* (% rel. intensity) 231 (M--Cl^−^, 100), 196 (84), 150 (8), 80 (8), 51 (5); HRMS (ESI): Calcd. for C~13~H~13~Cl~2~N~2~ \[M + H\]^+^: 267.0450; found: 267.0457.

**3-(4-Methylbenzyl)-2,5-dimethylpyrazine (2h):** yellow oil; ^1^H NMR (300 MHz, CDCl~3~) δ 8.18 (s, 1H), 7.10--7.00 (m, 4H), 4.10 (s, 2H), 2.49 (s, 3H), 2.42 (s, 3H), 2.25 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 152.9, 149.8, 149.0, 141.0, 135.6, 134.6, 128.9, 128.3, 41.0, 21.2, 20.8, 20.7; GCMS *m*/*z* (% rel. intensity) 212 (M^+^, 75), 211 (100), 197 (53), 128 (11), 105 (30), 77 (16); HRMS (ESI): Calcd. for C~14~H~17~N~2~ \[M + H\]^+^:213.1385; found: 213.1385.

**3-(4-Methoxybenzyl)-2,5-dimethylpyrazine (2i):** yellow solid; ^1^H NMR (300 MHz, CDCl~3~) δ 8.20 (s, 1H), 7.10 (d, 2H, *J* = 8.3 Hz), 6.81 (d, 2H, *J* = 8.2 Hz), 4.10 (s, 2H), 3.75 (s, 3H), 2.52 (s, 3H), 2.44 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 158.2, 153.3, 150.2, 149.3, 141.3, 130.0, 129.6, 113.9, 55.2, 40.9, 21.5, 21.1; GCMS *m*/*z* (% rel. intensity) 228 (M^+^, 100), 227 (44), 213 (74), 185 (17), 121 (87), 91 (14); HRMS (ESI): Calcd. for C~14~H~17~N~2~O \[M + H\]^+^: 229.1335; found: 229.1330.

**3-(2-Naphthylmethyl)-2,5-dimethylpyrazine (2j):** yellow oil; ^1^H NMR (300 MHz, CDCl~3~) δ 8.19 (s, 1H), 7.75--7.66 (m, 3H), 7.53 (s, 1H), 7.41--7.30 (m, 3H), 4.27 (s, 2H), 2.50 (s, 3H), 2.43 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 152.7, 150.1, 149.4, 141.4, 135.4, 133.4, 132.1, 128.1, 127.5, 127.4, 127.0, 126.8, 126.0, 125.4, 41.7, 21.4, 21.0; GCMS *m*/*z* (% rel. intensity) 248 (M^+^, 85), 247 (100), 233 (42), 141 (29), 115 (27); HRMS (ESI): Calcd. for C~17~H~17~N~2~ \[M + H\]^+^: 249.1386; found: 249.1392.

**3-Octyl-2,5-dimethylpyrazine (2k):** yellow oil; ^1^H NMR (300 MHz, CDCl~3~) δ 8.15 (s, 1H), 2.76 (t, 2H, *J* = 7.6 Hz), 2.53 (s, 3H), 2.49 (s, 3H), 1.73--1.62 (m, 2H), 1.48--1.21 (m, 10H), 0.88 (t, 3H, *J* = 6.5 Hz); ^13^C NMR (75 MHz, CDCl~3~) δ 154.9, 150.0, 148.5, 140.6, 35.2, 31.9, 29.7, 29.5, 29.3, 28.6, 22.7, 21.2, 21.1, 14.1; GCMS *m*/*z* (% rel. intensity) 135 (11), 122 (100); HRMS (ESI): Calcd. for C~14~H~25~N~2~ \[M + H\]^+^: 221.2012; found: 221.2019.

**3-Cinnamyl-2,5-dimethylpyrazine (2l):** orange oil; ^1^H NMR (300 MHz, CDCl~3~) δ 8.20 (s, 1H), 7.35--7.20 (m, 5H), 6.50--6.31 (m, 2H), 3.71 (d, 2H, *J* = 5.8 Hz), 2.55 (s, 3H), 2.50 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 152.4, 150.4, 149.1, 141.4, 137.2, 131.9, 128.5, 127.4, 126.2, 125.9, 39.2, 21.2, 21.1; GCMS *m*/*z* (% rel. intensity) 224 (M^+^, 47), 223 (28), 209 (34). 147 (45), 122 (100), 115 (27), 91 (15); HRMS (ESI): Calcd. for C~15~H~17~N~2~ \[M + H\]^+^: 225.1386; found: 225.1375.

**3-Cyclohexylmethyl-2,5-dimethylpyrazine (2m):** yellow oil; ^1^H NMR (300 MHz, CDCl~3~) δ 8.14 (s, 1H), 2.66 (d, 2H, *J* = 7.2 Hz), 2.52 (s, 3H), 2.50 (s, 3H), 1.85--1.63 (m, 6H), 1.29--0.99 (m, 5H); ^13^C NMR (75 MHz, CDCl~3~) δ 154.1, 150.0, 149.0, 140.6, 42.5, 38.3, 33.3, 26.5, 26.3, 21.6, 21.2; GCMS *m*/*z* (% rel. intensity) 204 (M^+^, 0.2), 189 (1), 161 (2), 147 (2), 122 (100), 80 (2), 55 (4); HRMS (ESI): Calcd. for C~13~H~21~N~2~ \[M + H\]^+^: 205.1699; found: 205.1702.

**3-(2-Furylmethyl)-2,5-dimethylpyrazine (2n):** yellow oil; ^1^H NMR (300 MHz, CDCl~3~) δ 8.23 (s, 1H), 7.31 (d, 1H, *J* = 1.1 Hz), 6.28 (d, 1H, *J* = 1.5 Hz), 6.00 (d, 1H, *J* = 3.1 Hz), 4.16 (s, 2H), 2.53 (s, 3H), 2.51 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 151.7, 150.6, 150.4, 149.4, 141.9, 141.7, 110.4, 106.7, 35.0, 21.3, 21.1; GCMS *m*/*z* (% rel. intensity) 188 (M^+^, 80), 159 (100), 145 (15), 91 (10), 81 (36); HRMS (ESI): Calcd. for C~11~H~17~N~2~O \[M + H\]^+^: 189.1022; found: 189.1017.

**2,5-Dimethyl-3-(2-thienylmethyl)pyrazine (2o):** yellow oil; ^1^H NMR (300 MHz, CDCl~3~) δ 8.22 (s, 1H), 7,13 (d, 1H, *J* = 6.5 Hz), 6.90 (dd, 1H, *J* = 3.4 Hz, 5.1 Hz), 6.78 (m, 1H), 4.32 (s, 2H), 2.52 (s, 6H); ^13^C NMR (75 MHz, CDCl~3~) δ 152.1, 150.4, 149.0, 141.8, 140.4, 126.8, 125.4, 124.3, 36.2, 21.3, 21.1; GCMS *m*/*z* (% rel. intensity) 204 (100), 189 (15), 171 (30), 159 (35), 97 (95), 80 (9), 53 (16); HRMS (ESI): Calcd. for C~11~H~13~N~2~S \[M + H\]^+^: 205.0794; found: 205.0790.

4. Conclusions
==============

In summary, we have developed a cascade annulation of propargyl amine with aldehydes approach to 3-substituted 2,5-dimethylpyrazines in high yields catalyzed by Au(PPh~2~Cy)Cl, which involves the intermolecular hydroamination and intramolecular cyclic hydroamination, as well as the dehydration reaction. The present work has developed the application of propargyl amines in the synthesis of nitrogen-containing heterocycles with the advantages of readily accessible starting materials and high atom-efficiency.
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